investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Prolactin pathways and metastatic progression of ER-positive breast cancer
Hallgeir Rui
4 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Marja T Nevalainen
Thomas Jefferson University
Philadelphia, United States
Elisabeth Galsgaard
Novo Nordisk (Denmark)
Copenhagen, Denmark
Christopher Ormandy
Garvan Institute of Medical Research
Darlinghurst, Australia
Serge Y Fuchs
University of Pennsylvania
Philadelphia, United States
Hallgeir Rui
Thomas Jefferson University
Philadelphia, United States
Related projects
Jennifer A Pietenpol
p63 and p73 Signaling in Cell Growth and Cancer
Breast
Joe W Gray
Model-based Predictions of Responses RTK Pathway Therapies
Breast
Thomas Ried
Identifying Diagnostic Markers for Cervical, Breast, and Prostate Cancer
Breast
Angela Parrish
Axin-induced Wnt signaling in mouse embryogenesis and Wnt-related cancers
Breast
Song Yao
Exome Array Analysis of Reproductive Aging and Breast Cancer in African Americans
Breast
Zhiyuan Shen
Alternative Mechanisms to Inactivate p53 during Oncogenesis
Breast
Tim Greten
Analysis of Cancer-Related Immune Suppressor Mechanisms in Mice
Breast
Richard A Anderson
PI Signaling Role in Epithelial/Mesenchymal Transition
Breast
William J Murphy
1 of 3 Interdisciplinary Collaboratory for Enhancing Translational Therapeutics Utilizing Biologically, Immunologically, and Metabollically Relevant Models of Breast Cancer
Breast